Cisplatin in Liver Cancer Therapy.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Jun 2023
Historique:
received: 12 05 2023
revised: 19 06 2023
accepted: 26 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often diagnosed at an unresectable advanced stage. Systemic chemotherapy as well as transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) are used to treat advanced HCC. TACE and HAIC have long been the standard of care for patients with unresectable HCC but are limited to the treatment of intrahepatic lesions. Systemic chemotherapy with doxorubicin or chemohormonal therapy with tamoxifen have also been considered, but neither has demonstrated survival benefits. In the treatment of unresectable advanced HCC, cisplatin is administered transhepatic arterially for local treatment. Subsequently, for cisplatin-refractory cases due to drug resistance, a shift to systemic therapy with a different mechanism of action is expected to produce new antitumor effects. Cisplatin is also used for the treatment of liver tumors other than HCC. This review summarizes the action and resistance mechanism of cisplatin and describes the treatment of the major hepatobiliary cancers for which cisplatin is used as an anticancer agent, with a focus on HCC.

Identifiants

pubmed: 37446035
pii: ijms241310858
doi: 10.3390/ijms241310858
pmc: PMC10341575
pii:
doi:

Substances chimiques

Cisplatin Q20Q21Q62J
Fluorouracil U3P01618RT

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Mol Med Rep. 2021 Jun;23(6):
pubmed: 33864660
J Clin Oncol. 2002 Jun 15;20(12):2798-804
pubmed: 12065556
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302
pubmed: 12370430
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
BJU Int. 2005 May;95(7):1086-90
pubmed: 15839938
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5672-6
pubmed: 8202546
Lancet Oncol. 2019 Feb;20(2):282-296
pubmed: 30665869
Kidney Int. 2007 Jul;72(1):5-7
pubmed: 17597786
Clin Biochem. 2019 Mar;65:45-52
pubmed: 30653948
J Clin Oncol. 2016 Apr 1;34(10):1050-6
pubmed: 26811523
Liver Cancer. 2019 Oct;8(5):299-311
pubmed: 31768341
Acta Oncol. 2009;48(6):832-41
pubmed: 19308757
Gan To Kagaku Ryoho. 2020 Dec;47(13):2251-2253
pubmed: 33468924
Cancers (Basel). 2023 Jan 20;15(3):
pubmed: 36765612
Tumori. 2007 Mar-Apr;93(2):138-44
pubmed: 17557559
Pediatr Blood Cancer. 2006 Aug;47(2):174-82
pubmed: 16086410
Support Care Cancer. 2022 Apr;30(4):3345-3351
pubmed: 34984552
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Sci Rep. 2017 Jan 11;7:40384
pubmed: 28074905
PLoS One. 2014 Oct 02;9(10):e109347
pubmed: 25275448
J Cancer Res Clin Oncol. 2011 Apr;137(4):659-67
pubmed: 20552225
Int J Mol Sci. 2022 Dec 06;23(23):
pubmed: 36499737
Eur J Med Chem. 2022 Dec 5;243:114680
pubmed: 36152386
Pediatrics. 2010 Apr;125(4):e938-50
pubmed: 20194279
Cell Biol Int. 2021 Dec;45(12):2521-2533
pubmed: 34486197
Ann Pharmacother. 2012 Feb;46(2):276-81
pubmed: 22298599
J Nucleic Acids. 2010 Aug 08;2010:
pubmed: 20811617
Mutat Res. 1997 Jun 13;391(1-2):79-86
pubmed: 9219551
Liver Cancer. 2022 Feb 15;11(4):383-396
pubmed: 35978602
Lancet Oncol. 2009 Jan;10(1):25-34
pubmed: 19095497
Anticancer Res. 2016 Jul;36(7):3555-63
pubmed: 27354623
Ann Surg. 1995 Jun;221(6):734-41; discussion 731-43
pubmed: 7794077
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
J Hepatocell Carcinoma. 2017 Jan 16;4:15-21
pubmed: 28144610
BMC Complement Altern Med. 2014 Aug 03;14:282
pubmed: 25088145
N Engl J Med. 2019 Sep 19;381(12):1124-1135
pubmed: 31150573
Cancer Res. 2012 Sep 15;72(18):4616-21
pubmed: 22962276
Clin Exp Nephrol. 2009 Dec;13(6):578-84
pubmed: 19629622
FEBS Lett. 1997 Sep 15;414(3):552-6
pubmed: 9323034
Drug Metab Dispos. 2018 May;46(5):592-599
pubmed: 29514829
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
J Am Soc Nephrol. 2006 Mar;17(3):765-74
pubmed: 16481417
Front Mol Neurosci. 2017 May 31;10:174
pubmed: 28620280
EMBO J. 1997 Dec 15;16(24):7444-56
pubmed: 9405373
Cancer Sci. 2013 Sep;104(9):1211-6
pubmed: 23763511
Biochem Pharmacol. 1990 Sep 15;40(6):1329-36
pubmed: 2206139
BMC Cancer. 2018 Jun 4;18(1):633
pubmed: 29866075
Drug Des Devel Ther. 2022 Apr 26;16:1191-1198
pubmed: 35502425
J Clin Oncol. 1992 May;10(5):795-803
pubmed: 1569451
Clin Pharmacol Ther. 2009 Oct;86(4):396-402
pubmed: 19625999
Kidney Int. 2003 Jan;63(1):72-82
pubmed: 12472770
Cell Death Dis. 2014 Oct 30;5:e1505
pubmed: 25356874
Heliyon. 2022 Sep 14;8(9):e10608
pubmed: 36158077
Mol Cell Biochem. 2020 Dec;475(1-2):79-91
pubmed: 32761300
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F35-47
pubmed: 25947343
BMC Cancer. 2015 Oct 19;15:731
pubmed: 26482648
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
Liver Cancer. 2015 Sep;4(3):188-99
pubmed: 26674592
Cancer Res. 2008 Nov 1;68(21):8643-53
pubmed: 18974103
Med Pediatr Oncol. 2002 Nov;39(5):519-23
pubmed: 12228910
Metallomics. 2014 Nov;6(11):2126-33
pubmed: 25306996
Cardiovasc Intervent Radiol. 2022 Oct;45(10):1430-1440
pubmed: 35978174
Biochemistry. 1986 Jul 1;25(13):3912-5
pubmed: 3741840
Br J Cancer. 1999 Mar;79(7-8):1104-10
pubmed: 10098743
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cell Death Differ. 2008 Mar;15(3):530-44
pubmed: 18064040
Lancet Oncol. 2017 Jan;18(1):122-131
pubmed: 27884679
Lancet Oncol. 2015 Aug;16(8):967-78
pubmed: 26179201
J Pharmacol Exp Ther. 2006 Nov;319(2):879-86
pubmed: 16914559
Br J Cancer. 2023 Mar;128(5):907-917
pubmed: 36526676
Cancer Res. 2002 Nov 15;62(22):6559-65
pubmed: 12438251
Clin Cancer Res. 2000 Jun;6(6):2401-7
pubmed: 10873092
Cancer Chemother Pharmacol. 2018 Sep;82(3):469-478
pubmed: 29982870
Semin Hear. 2019 May;40(2):197-204
pubmed: 31036996
Toxins (Basel). 2010 Nov;2(11):2490-518
pubmed: 22069563
J Cell Physiol. 2006 Aug;208(2):267-73
pubmed: 16523492
Food Chem Toxicol. 2020 Feb;136:111079
pubmed: 31891754
J Am Chem Soc. 2008 Mar 5;130(9):2851-61
pubmed: 18269283
Oncotarget. 2017 Jul 6;8(35):59950-59964
pubmed: 28938696
Liver Cancer. 2022 Feb 10;11(4):354-367
pubmed: 35978604
N Engl J Med. 2018 Sep 20;379(12):1181
pubmed: 30231227
Drug Saf. 2009;32(12):1109-22
pubmed: 19916578
Clin Transl Med. 2022 Jun;12(6):e848
pubmed: 35696608
Hepatology. 2003 Feb;37(2):429-42
pubmed: 12540794
J Hepatocell Carcinoma. 2021 May 26;8:477-492
pubmed: 34079777
J Clin Oncol. 2008 Aug 1;26(22):3749-55
pubmed: 18669462
N Engl J Med. 2018 Jul 05;379(1):54-63
pubmed: 29972759
Cancers (Basel). 2022 Aug 20;14(16):
pubmed: 36011021
Toxics. 2015 Jul 15;3(3):268-293
pubmed: 29051464
Cardiovasc Intervent Radiol. 2012 Feb;35(1):82-9
pubmed: 21203761
Biochemistry. 1998 Nov 17;37(46):16307-15
pubmed: 9819223
Biochem Pharmacol. 2012 Apr 15;83(8):1049-62
pubmed: 22227014
Acta Pharmacol Sin. 2021 Dec;42(12):1951-1969
pubmed: 33750909
World J Gastroenterol. 2013;19(14):2242-8
pubmed: 23599651
J Hepatol. 2017 Jul;67(1):173-183
pubmed: 28323121
Biochem Pharmacol. 2022 Dec;206:115323
pubmed: 36368406
Hepatol Int. 2017 Jul;11(4):317-370
pubmed: 28620797
J Hepatol. 2022 Dec;77(6):1690-1698
pubmed: 35977611
Eur J Cancer. 2004 Feb;40(3):411-21
pubmed: 14746860
Br J Cancer. 2010 Aug 10;103(4):469-74
pubmed: 20628385
Cancer Sci. 2014 Mar;105(3):354-8
pubmed: 24438504
Mol Ther Nucleic Acids. 2020 Mar 6;19:384-392
pubmed: 31887549
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Cancer Lett. 2019 Nov 1;464:5-14
pubmed: 31404614
J Oncol. 2014;2014:767652
pubmed: 25328521
Cancer Invest. 2022 Jan;40(1):81-89
pubmed: 34236269
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):522-532
pubmed: 35278356
Eur J Cancer. 2023 Jan;179:1-14
pubmed: 36463640
Br J Cancer. 2009 Aug 18;101(4):621-7
pubmed: 19672264
J Ovarian Res. 2014 Apr 09;7:38
pubmed: 24713296
Cancer. 2007 Jul 1;110(1):129-37
pubmed: 17508408
Anticancer Res. 2016 Apr;36(4):1873-7
pubmed: 27069173
Oncologist. 2017 May;22(5):609-619
pubmed: 28438887
Support Care Cancer. 2016 Apr;24(4):1789-93
pubmed: 26446698
J Feline Med Surg. 2018 Dec;20(12):1124-1129
pubmed: 29360017
J Hepatol. 2022 Mar;76(3):681-693
pubmed: 34801630
J Clin Oncol. 2000 Nov 15;18(22):3819-28
pubmed: 11078495
Int J Biochem Cell Biol. 2013 May;45(5):960-3
pubmed: 23391749
Antioxid Redox Signal. 2012 Jun 1;16(11):1295-322
pubmed: 22117137
Lancet. 2005 Oct 8;366(9493):1303-14
pubmed: 16214602
J Transl Med. 2018 Apr 11;16(1):96
pubmed: 29642900
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Cancer Chemother Pharmacol. 2015 Feb;75(2):293-300
pubmed: 25477010
Anticancer Res. 2022 Mar;42(3):1263-1275
pubmed: 35220216
Biochem Pharmacol. 2023 Jan;207:115373
pubmed: 36513143
Clin Cancer Res. 2008 Jun 15;14(12):3875-80
pubmed: 18559608
J Clin Invest. 2002 Sep;110(6):835-42
pubmed: 12235115
Int J Mol Sci. 2023 Jan 12;24(2):
pubmed: 36675064
Drug Metab Rev. 1999 Nov;31(4):971-97
pubmed: 10575556
Cancer Chemother Pharmacol. 2016 Jan;77(1):19-26
pubmed: 26589789
Pediatr Blood Cancer. 2014 Nov;61(11):2018-23
pubmed: 25044669
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Histopathology. 2021 Jul;79(1):36-46
pubmed: 33326644
Radiol Oncol. 2019 Mar 28;53(2):148-158
pubmed: 30956230
Int J Mol Sci. 2021 Jul 30;22(15):
pubmed: 34360968
Nature. 1965 Feb 13;205:698-9
pubmed: 14287410
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432
pubmed: 29631810
Carcinogenesis. 1985 Apr;6(4):561-6
pubmed: 4039227
PLoS One. 2013 Nov 19;8(11):e81162
pubmed: 24260552
BMC Cancer. 2019 Oct 15;19(1):954
pubmed: 31615466
J Oncol Pharm Pract. 2021 Jan;27(1):180-186
pubmed: 32990190
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Liver Cancer. 2022 Jan 4;11(3):192-208
pubmed: 35949289
Int J Mol Sci. 2022 Jul 08;23(14):
pubmed: 35886942
Chem Biol. 2010 Dec 22;17(12):1334-43
pubmed: 21168769
Medicine (Baltimore). 2018 Dec;97(52):e13807
pubmed: 30593170
Nat Rev Cancer. 2007 Aug;7(8):573-84
pubmed: 17625587
Mol Pharmacol. 2013 Jun;83(6):1237-46
pubmed: 23543413
Cureus. 2022 Aug 26;14(8):e28439
pubmed: 36176866
Cancer Sci. 2008 Oct;99(10):2037-44
pubmed: 19016764
Medicine (Baltimore). 2020 Jun 26;99(26):e20745
pubmed: 32590750
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Oct 18;54(5):971-980
pubmed: 36241241
Lancet Oncol. 2019 Jan;20(1):e29-e41
pubmed: 30614474
Biochim Biophys Acta. 2016 Dec;1863(12):2977-2992
pubmed: 27646922
Sci China Life Sci. 2017 Oct;60(10):1114-1124
pubmed: 29039125
Pediatr Blood Cancer. 2016 Jul;63(7):1152-62
pubmed: 26928933
Front Oncol. 2022 Aug 01;12:930868
pubmed: 35978834
Int J Clin Oncol. 2020 Nov;25(11):1928-1935
pubmed: 32740717
Cancer Chemother Pharmacol. 1980;5(1):21-6
pubmed: 6161715
Front Oncol. 2022 Apr 21;12:846965
pubmed: 35530314
Cancers (Basel). 2020 May 17;12(5):
pubmed: 32429551
Oncol Rep. 2010 Apr;23(4):965-72
pubmed: 20204280
Oncol Lett. 2018 Sep;16(3):3267-3273
pubmed: 30127924
Front Pharmacol. 2017 Feb 24;8:86
pubmed: 28286483
Sci Data. 2023 Jan 18;10(1):33
pubmed: 36653372
Cancers (Basel). 2011 Mar 15;3(1):1351-71
pubmed: 24212665
Clin Cancer Res. 2006 Oct 1;12(19):5817-25
pubmed: 17020989
Cancer Lett. 2006 Mar 8;234(1):34-9
pubmed: 16297532
Biomolecules. 2022 Sep 24;12(10):
pubmed: 36291573
Metallomics. 2021 Apr 30;13(5):
pubmed: 33770183
Clin J Gastroenterol. 2022 Dec;15(6):1101-1107
pubmed: 36088514
Cancer Res. 2008 Apr 15;68(8):2581-6
pubmed: 18413725
Am J Med Sci. 2007 Aug;334(2):115-24
pubmed: 17700201
Mol Clin Oncol. 2021 Aug;15(2):154
pubmed: 34178325
Lancet Child Adolesc Health. 2020 Feb;4(2):141-150
pubmed: 31866182
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909387
J Biol Chem. 1998 Jun 12;273(24):14721-30
pubmed: 9614070
Nature. 1969 Apr 26;222(5191):385-6
pubmed: 5782119
J Biomed Sci. 2019 Mar 13;26(1):25
pubmed: 30866950
Mol Cancer Ther. 2011 Jul;10(7):1161-72
pubmed: 21566064
Cancers (Basel). 2021 Jun 21;13(12):
pubmed: 34205656
Int J Clin Oncol. 2016 Feb;21(1):81-7
pubmed: 26093520
Int J Mol Sci. 2022 Jun 29;23(13):
pubmed: 35806243
Bull Cancer. 2012 Apr 1;99(4):E43-8
pubmed: 22450449
Front Biosci (Elite Ed). 2012 Jan 01;4(1):470-9
pubmed: 22201887
Nat Rev Cancer. 2011 Jun 24;11(7):467-80
pubmed: 21701511
Hepatology. 2021 Apr;73(4):1381-1398
pubmed: 32609900
Nature. 2008 Feb 28;451(7182):1116-20
pubmed: 18264087
Hear Res. 2007 Apr;226(1-2):92-103
pubmed: 17224251
Biometals. 2016 Dec;29(6):1075-1083
pubmed: 27787693
Kaohsiung J Med Sci. 2011 Aug;27(8):314-22
pubmed: 21802642
Cancer Invest. 2017 Apr 21;35(4):271-276
pubmed: 28272913
Curr Mol Med. 2018;18(6):343-351
pubmed: 30411685
Cancer Res. 2013 Jul 15;73(14):4451-60
pubmed: 23695549
Met Based Drugs. 2010;2010:
pubmed: 20885916
Front Oncol. 2022 Sep 28;12:980214
pubmed: 36249023
Int J Mol Sci. 2018 Aug 01;19(8):
pubmed: 30071606
Cancers (Basel). 2019 Jul 31;11(8):
pubmed: 31370183
Lancet. 2022 Oct 15;400(10360):1345-1362
pubmed: 36084663
Pharmacol Rev. 2012 Jul;64(3):706-21
pubmed: 22659329
J Clin Oncol. 2005 Dec 1;23(34):8588-96
pubmed: 16314621
Eur J Cancer. 2016 Jan;52:92-101
pubmed: 26655560
Pediatr Blood Cancer. 2012 Apr;58(4):539-44
pubmed: 21922643
Crit Rev Oncol Hematol. 2009 Mar;69(3):259-70
pubmed: 18977670
J Clin Med Res. 2016 Apr;8(4):297-302
pubmed: 26985249
Oncol Rep. 2013 Apr;29(4):1285-92
pubmed: 23404427
Front Oncol. 2022 Nov 30;12:1021632
pubmed: 36531039
Am J Physiol Renal Physiol. 2009 Mar;296(3):F505-11
pubmed: 19144690
J Clin Invest. 2019 Nov 1;129(11):5033-5049
pubmed: 31437128
Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F369-84
pubmed: 24944268
J Vasc Interv Radiol. 2001 Jul;12(7):847-54
pubmed: 11435541
Anticancer Drugs. 2011 Mar;22(3):277-82
pubmed: 21360850
World J Gastroenterol. 2021 Oct 21;27(39):6527-6550
pubmed: 34754151
J Inorg Biochem. 2012 Nov;116:1-10
pubmed: 23010323
World J Gastroenterol. 2018 Sep 21;24(35):3980-3999
pubmed: 30254403
World J Clin Oncol. 2016 Feb 10;7(1):106-13
pubmed: 26862494
Bioorg Chem. 2019 Jul;88:102925
pubmed: 31003078
Ann Oncol. 2016 Nov;27(11):2090-2096
pubmed: 27573564
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):386-90
pubmed: 15313674
Biochem Pharmacol. 2004 Jul 15;68(2):283-91
pubmed: 15194000
JCO Glob Oncol. 2022 Mar;8:e2100275
pubmed: 35436142
Eur J Pharmacol. 2014 Oct 5;740:364-78
pubmed: 25058905
Hong Kong Med J. 2002 Feb;8(1):13-7
pubmed: 11861987
Int J Cancer. 2020 Jul 15;147(2):317-330
pubmed: 31597196
Cancer Immunol Res. 2017 Dec;5(12):1141-1151
pubmed: 29097421
Aliment Pharmacol Ther. 2006 Jun 1;23(11):1535-47
pubmed: 16696801
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2076-80
pubmed: 7892227
Eur J Clin Pharmacol. 2020 Jan;76(1):23-33
pubmed: 31677116
Kidney Int. 2007 Jul;72(1):37-44
pubmed: 17396112

Auteurs

Sae Hamaya (S)

Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Kita-gun 761-0793, Japan.

Kyoko Oura (K)

Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Kita-gun 761-0793, Japan.

Asahiro Morishita (A)

Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Kita-gun 761-0793, Japan.

Tsutomu Masaki (T)

Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Kita-gun 761-0793, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH